Clinical Trial 43567

Tustin, CA 92780


Summary:

Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) Who Have an Inadequate Response with, Lost Response to, or Were Intolerant to Standard Therapies


Qualified Participants Must:

• Must be 18 to 80 years old
• Been diagnosed with Eosinophilic Gatritis (ES), Eosiniphilic Duodenitis (EOD) (AKA Eosinophilic Gasroenteritis/EGE)
• Willing to comply with all study procedures


Qualified Participants May Receive:

Up to $3800.00


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.